Myoview patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9549999 GE HEALTHCARE Radiopharmaceutical composition
Mar, 2030

(6 years from now)

Myoview is owned by Ge Healthcare.

Myoview contains Technetium Tc-99M Tetrofosmin Kit.

Myoview has a total of 1 drug patent out of which 0 drug patents have expired.

Myoview was authorised for market use on 09 February, 1996.

Myoview is available in injectable;injection dosage forms.

The generics of Myoview are possible to be released after 10 March, 2030.

Drugs and Companies using TECHNETIUM TC-99M TETROFOSMIN KIT ingredient

Market Authorisation Date: 09 February, 1996

Treatment: NA


More Information on Dosage

MYOVIEW family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic